Team identifies drugs that halt skin cancer metastasis in lab tests

There’s a reason why melanoma, the most serious type of skin cancer, is so aggressive. You just need to watch the cells in action. Researchers at the University of Iowa did just that, documenting in real time and in 3-D how melanoma cells form tumors. The cells waste no time finding their cancerous cousins, slashing their way through a lab-prepared gel to quickly join other melanoma cells and form tumors. read more Dr Stegall’s Comments: The communication network between cancer … Read More

How cancer cells develop resistance

Study identifies how cancer cells may develop resistance to FGFR inhibitors A mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibitors has now been uncovered by investigators. The researchers also found that use of a second inhibitor might improve the effectiveness of these drugs by possibly preventing resistance, and it recommends that clinical trials should be designed to include a second inhibitor. read more Dr. Stegall’s comments: One of the … Read More

Early cancer detection, some new technologies on the horizon

Urine-based biomarkers for early cancer screening test A new study has introduced a new technique that validates urine-based biomarkers for early detection of cancer. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics. read more Dr. Stegall’s comments: As I always say, the more tools we have in our tool chest, the better. One of the challenges in oncology has been detecting and monitoring cancer. I am excited … Read More

Poly-MVA – An integrative approach to the treatment of cancer

What does Poly-MVA mean for the cancer patient? Poly-MVA is a liquid supplement, taken orally. The good news is, it is backed by good research data. Reputable physicians are using it with good result. It is not a drug, but a dietary supplement, so it is safe, non-toxic, no side effects. It can be taken orally, although the doctors who use it prefer to start intravenously, and only later do they switch to oral intake. According to posted literature, it … Read More

Promising new treatments in the fight against cancer

– The future of cancer treatment, part two The Promise of Chimeric Antigen Receptor T-Cell Therapy Chimeric antigen receptors (CARs) are engineered molecules that can be introduced into T cells to enable them to target specific tumor antigens. CAR T cells targeting CD19 have shown promise in patients with relapsed and refractory B-cell neoplasms, including those with acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphomas. Cancer immunotherapy aims to harness the antitumor potential of the immune system and translate … Read More

Cancer treatment – looking towards the future

– The future of cancer treatment, part one. This week we take a look at some promising new cancer treatments… We have something like 14 million cells in our body, but only one in three of us, and over many years, gets cancer (defined by the uncontrolled division of cells which grow to form tumor). At the cellular level, cancer is extremely rare, and this is because we have mechanisms that block mutated cells progressing towards disease. We study these … Read More

World Pancreatic Cancer Day November 17, 2016

What is pancreatic cancer? Pancreatic cancer is an aggressive disease with an extremely high mortality rate, mainly because it does not present any symptoms in its early stages and is highly resistant to chemotherapy. Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas of the body. Pancreatic cancer begins when cells in the pancreas start to grow uncontrollably. The pancreas … Read More